Evidence-gap map · non-drug interventions

Sarcopenia evidence gaps

544 registered non-drug trials, mapped by approach and outcome.

Which non-drug approaches have been tested for Sarcopenia, and which outcomes they were tested on. An empty cell means no matching trial was found among those searched: a possible gap, not proof that nobody has asked the question.

544registered non-drug trials
26with results posted
73recruiting as of 2026-11-16
87group × outcome cells with at least one trial
⚠️
Research information, not medical advice. These pages index what has been studied in registered trials. A trial existing, completing or posting results says nothing on its own about whether an approach works or is safe for you. Supplements and devices can interact with medicines. Discuss any change with your own clinician.

Evidence-gap matrix

Each number is the count of trials; "with results" is how many of them have posted results on ClinicalTrials.gov. A trial is counted once per group and per outcome domain it covers. The number in brackets after each group is its total trials for this condition.

none1–23–910–2930 or more
Registered non-drug trials for Sarcopenia by intervention group and primary outcome domain
Intervention groupFatigue and energyPost-exertional symptomsCognitionMood, anxiety and wellbeingPainSleepPhysical function and exercise capacityHeart rate, blood pressure and autonomicBreathing and lung functionQuality of lifeWeight and metabolic markersInflammation and other biomarkersSymptom severity and disease activityClinical events, survival and healthcare useFeasibility, adherence and safetyNot classified
Exercise and physical activity (289)9·142 with results8451858 with results103 with results614463 with results521 with results8514361 with results
Rehabilitation and therapy services (24)··1···191 with results···11 with results3·3·2
Breathing and respiratory training (5)······4·3··1···1
Mind-body and psychological approaches (17)··32··132 with results1·331 with results4····
Cognitive training and education (17)1·111181 with results··121·311 with results1
Diet, fasting and nutrition (51)2·11·1281·415142348
Sleep and circadian approaches (1)·····11·1··1····
Neuromodulation and electrical stimulation (11)······8···11·2·1
Oxygen, light, temperature and manual therapies (12)······7····2···3
Supplements and nutraceuticals (185)3·102 with results6··952 with results12436495 with results3181 with results331 with results
Other behavioural, not yet classified (43)1·441 with results1·243 with results21 with results1581 with results72221 with results7

The table scrolls sideways: 16 outcome columns.

No trials found for this condition in: Other devices and digital tools; Care delivery and health services.

Where the gaps are

Outcomes not found as a primary outcome in a group's trials

  • Among the 12 trials of oxygen, light, temperature and manual therapies found, none used weight and metabolic markers as a primary outcome (87 trials of other approaches did).
  • Among the 12 trials of oxygen, light, temperature and manual therapies found, none used cognition as a primary outcome (30 trials of other approaches did).
  • Among the 11 trials of neuromodulation and electrical stimulation found, none used cognition as a primary outcome (30 trials of other approaches did).
  • Among the 24 trials of rehabilitation and therapy services found, none used quality of life as a primary outcome (25 trials of other approaches did).
  • Among the 12 trials of oxygen, light, temperature and manual therapies found, none used quality of life as a primary outcome (25 trials of other approaches did).
  • Among the 11 trials of neuromodulation and electrical stimulation found, none used quality of life as a primary outcome (25 trials of other approaches did).
  • Among the 24 trials of rehabilitation and therapy services found, none used mood, anxiety and wellbeing as a primary outcome (19 trials of other approaches did).
  • Among the 12 trials of oxygen, light, temperature and manual therapies found, none used mood, anxiety and wellbeing as a primary outcome (19 trials of other approaches did).
  • Among the 11 trials of neuromodulation and electrical stimulation found, none used mood, anxiety and wellbeing as a primary outcome (19 trials of other approaches did).
  • Among the 17 trials of mind-body and psychological approaches found, none used clinical events, survival and healthcare use as a primary outcome (15 trials of other approaches did).
  • Among the 12 trials of oxygen, light, temperature and manual therapies found, none used clinical events, survival and healthcare use as a primary outcome (15 trials of other approaches did).
  • Among the 24 trials of rehabilitation and therapy services found, none used symptom severity and disease activity as a primary outcome (13 trials of other approaches did).
  • Among the 17 trials of mind-body and psychological approaches found, none used symptom severity and disease activity as a primary outcome (13 trials of other approaches did).
  • Among the 17 trials of cognitive training and education found, none used symptom severity and disease activity as a primary outcome (13 trials of other approaches did).

Questions studied but with no results posted

  • Supplements and nutraceuticals × weight and metabolic markers: 36 trials registered, none with results posted (3 still recruiting)
  • Diet, fasting and nutrition × physical function and exercise capacity: 28 trials registered, none with results posted (5 still recruiting)
  • Diet, fasting and nutrition × weight and metabolic markers: 15 trials registered, none with results posted (2 still recruiting)
  • Exercise and physical activity × quality of life: 14 trials registered, none with results posted (1 still recruiting)
  • Exercise and physical activity × feasibility, adherence and safety: 14 trials registered, none with results posted (3 still recruiting)
  • Diet, fasting and nutrition × inflammation and other biomarkers: 14 trials registered, none with results posted (2 still recruiting)
  • Exercise and physical activity × fatigue and energy: 9 trials registered, none with results posted (1 still recruiting)
  • Exercise and physical activity × mood, anxiety and wellbeing: 8 trials registered, none with results posted
  • Exercise and physical activity × symptom severity and disease activity: 8 trials registered, none with results posted (1 still recruiting)
  • Neuromodulation and electrical stimulation × physical function and exercise capacity: 8 trials registered, none with results posted
  • Oxygen, light, temperature and manual therapies × physical function and exercise capacity: 7 trials registered, none with results posted (1 still recruiting)
  • Exercise and physical activity × breathing and lung function: 6 trials registered, none with results posted (4 still recruiting)
  • Supplements and nutraceuticals × mood, anxiety and wellbeing: 6 trials registered, none with results posted
  • Exercise and physical activity × sleep: 5 trials registered, none with results posted (3 still recruiting)

Design a trial with DecenTrial (beta) Fund a component of this work

A gap here means no matching trial was found among those searched, not that an approach would work. About one trial in six has primary outcomes the rules cannot classify, so a few gaps may be measured under another name. Some gaps are gaps for good reason.

Most-studied approaches for Sarcopenia

Download this matrix (CSV) Non-drug evidence map Evidence brief RepurpOS condition page

How outcomes are grouped

Each trial's primary outcome measures are sorted into domains by keyword rules. 80 trials for this condition have primary outcomes the rules could not classify; they appear in the last column rather than being dropped. Checked against 90 hand-labelled outcomes; on a held-out sample of 30, the rules agreed with the hand label for 20 before adjustment, and every outcome they labelled was labelled correctly (misses were left unclassified).

Trial selection and exclusions follow the non-drug evidence map method. Source: ClinicalTrials.gov, searched 2026-11-16.